NeoIPC - Establishing innovative approaches for optimal infection prevention of resistant bacteria in NICUs by integrating research, implementation science and surveillance in a sustainable global platform / Edukad projektid

acronym:	NeoIPC
start:	2021-04-01
end:	2026-03-31

programme:	H2020 - Horisont 2020
sub-programme:	HEALTH - Tervishoid, demograafilised muutused ja heaolu
instrument:	RIA
call identifier:	H2020-SC1-2020-Single-Stage-RTD
project number:	965328
duration in months:	60
partner count:	13

abstract:	Around 10% of newborns in Europe will be admitted to a neonatal intensive care unit (NICU). Critically ill babies are a highly vulnerable population for the acquisition of resistant bacteria. Sepsis is among the most common events in NICU and is known to

partner no and role		partner name	country	contact person	web page
1	coordinator	UNIVERSITA DEGLI STUDI DI PADOVA	IT	Eugenio Baraldi	www.unipd.it
2	partner	ST GEORGE'S HOSPITAL MEDICAL SCHOOL	UK		www.sgul.ac.uk
3	partner	UNIVERSITAIR MEDISCH CENTRUM UTRECHT	NL		www.umcutrecht.nl
4	partner	UNIVERSITAT ZURICH	CH		http://www.uzh.ch
5	partner	TARTU ULIKOOL	EE		www.ut.ee
6	partner	SCHWEIZERISCHES TROPEN- UND PUBLIC HEALTH-INSTITUT	CH		www.swisstph.ch
7	partner	ARISTOTELIO PANEPISTIMIO THESSALONIKIS	EL		www.auth.gr
8	partner	UNIVERSITEIT ANTWERPEN	BE		www.uantwerpen.be
9	partner	CHARITE - UNIVERSITAETSMEDIZIN BERLIN	DE		www.charite.de
10	partner	Servicio Vasco de Salud Osakidetza	ES		http://www.osakidetza.euskadi.net/v19-oskhome/es/
11	partner	STELLENBOSCH UNIVERSITY	ZA
12	partner	FONDAZIONE PENTA - FOR THE TREATMENT AND CARE OF CHILDREN WITH HIV ANDRELATED DISEASES - ONLUS	IT		www.penta-id.org